![Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer | BMC Cancer | Full Text Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-13-543/MediaObjects/12885_2012_Article_4161_Fig1_HTML.jpg)
Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer | BMC Cancer | Full Text
![Diagnostics | Free Full-Text | Comparison of the Ultrasound Visibility of Tissue Markers in Metastatic Lymph Nodes after Neoadjuvant Chemotherapy in Patients with Breast Cancer Diagnostics | Free Full-Text | Comparison of the Ultrasound Visibility of Tissue Markers in Metastatic Lymph Nodes after Neoadjuvant Chemotherapy in Patients with Breast Cancer](https://www.mdpi.com/diagnostics/diagnostics-12-02424/article_deploy/html/images/diagnostics-12-02424-ag.png)
Diagnostics | Free Full-Text | Comparison of the Ultrasound Visibility of Tissue Markers in Metastatic Lymph Nodes after Neoadjuvant Chemotherapy in Patients with Breast Cancer
![Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study | HTML Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study | HTML](https://www.mdpi.com/cancers/cancers-11-00733/article_deploy/html/images/cancers-11-00733-g001-550.jpg)
Cancers | Free Full-Text | Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study | HTML
![CA 72-4 marker: adjunct to conventional biomarkers in monitoring of pancreatic, ovarian and colorectal cancers. - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc. CA 72-4 marker: adjunct to conventional biomarkers in monitoring of pancreatic, ovarian and colorectal cancers. - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc.](https://www.advimmuno.com/wp-content/uploads/2019/04/CA72-4.jpeg)
CA 72-4 marker: adjunct to conventional biomarkers in monitoring of pancreatic, ovarian and colorectal cancers. - Advanced ImmunoChemical Inc.Advanced ImmunoChemical Inc.
![A blood tumor marker combination assay produces high sensitivity and specificity for cancer according to the natural history - Kobayashi - 2018 - Cancer Medicine - Wiley Online Library A blood tumor marker combination assay produces high sensitivity and specificity for cancer according to the natural history - Kobayashi - 2018 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9a873d30-ab93-411f-ba8c-d780e23a68b9/cam41275-fig-0001-m.jpg)
A blood tumor marker combination assay produces high sensitivity and specificity for cancer according to the natural history - Kobayashi - 2018 - Cancer Medicine - Wiley Online Library
![Laboratory Medicine Practice Guidelines Use of Tumor Markers in Liver , Bladder , Cervical , and Gastric Cancers | Semantic Scholar Laboratory Medicine Practice Guidelines Use of Tumor Markers in Liver , Bladder , Cervical , and Gastric Cancers | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c5d851b9cef77d161e9a244d49ddbc1576a09732/38-Table6-1.png)
Laboratory Medicine Practice Guidelines Use of Tumor Markers in Liver , Bladder , Cervical , and Gastric Cancers | Semantic Scholar
![Elevated Gastric Juice Carbohydrate Antigen 72.4 (Ca 72.4) Is an Independent Prognostic Factor of Poor Survival for Gastric Cancer Patients | Anticancer Research Elevated Gastric Juice Carbohydrate Antigen 72.4 (Ca 72.4) Is an Independent Prognostic Factor of Poor Survival for Gastric Cancer Patients | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/40/3/1691/F2.large.jpg)
Elevated Gastric Juice Carbohydrate Antigen 72.4 (Ca 72.4) Is an Independent Prognostic Factor of Poor Survival for Gastric Cancer Patients | Anticancer Research
Diagnostic, prognostic and monitoring value of CA 72.4 in gastric cancer A prospective study including CA 19.9 and CEA
![Evaluation of a novel ELISA for the tumor-associated antigen CA 72–4 in patients with ovarian cancer | Future Science OA Evaluation of a novel ELISA for the tumor-associated antigen CA 72–4 in patients with ovarian cancer | Future Science OA](https://www.future-science.com/cms/10.4155/fsoa-2016-0040/asset/images/medium/figure1.gif)